Metabolic Syndrome and Recurrence According to the 21-Gene Recurrence Score in Node-Negative Breast Cancer


Metabolic Syndrome and Recurrence According to the 21-Gene Recurrence Score in Node-Negative Breast Cancer
Slides from a presentation at SABCS 2012 and transcribed comments from a recent interview with Lisa A Carey, MD (1/17/13)

Lakhani A et al. Metabolic syndrome and recurrence within the 21-gene Recurrence Score assay risk categories in lymph node negative breast cancer. San Antonio Breast Cancer Symposium 2012;Abstract PD10-02.

Dr Carey is Richardson and Marilyn Jacobs Preyer Distinguished Professor for Breast Cancer Research, Chief of the Division of Hematology and Oncology, Physician-in-Chief at the North Carolina Cancer Hospital and Associate Director for Clinical Research at the Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina.